← Browse by Condition
Medical Condition

suicide attempted

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for suicide attempted sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — suicide attempted Clinical Trials

How many clinical trials are currently recruiting for suicide attempted?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for suicide attempted, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for suicide attempted?
suicide attempted research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a suicide attempted clinical trial?
Eligibility criteria for suicide attempted trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Hôpital le Vinatier 1 trial
University Hospital, Ghent 1 trial
Massachusetts General Hospital 1 trial
Tatiana Falcone, MD 1 trial
Jennifer Hughes 1 trial

Recruiting Clinical Trials

NCT05609487
Recruiting
Evaluation of the Safety Plan to Prevent Suicidal Reiteration
Enrollment
2,387 pts
Location
France
Sponsor
Hôpital le Vinatier
View Trial →
NCT05638204
Recruiting
Effectiveness of the Suicidal Crisis Intervention (SCI)
Enrollment
390 pts
Location
Belgium
Sponsor
University Hospital, Ghent
View Trial →
NCT05825820
Recruiting
Pilot Study of Health System/Community Partnership for Enhanced Outreach to Prevent Suicide Attempts
Enrollment
20 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT04763343 Phase 3
Recruiting
Ketamine Treatment of Youth Suicide Attempters
Enrollment
60 pts
Location
United States
Sponsor
Tatiana Falcone, MD
View Trial →
NCT06476886
Recruiting
Intensive Crisis Intervention
Enrollment
213 pts
Location
United States
Sponsor
Jennifer Hughes
View Trial →
NCT06614946
Recruiting
Improving Coping to Reduce Suicide Risk Following ED Discharge
Enrollment
120 pts
Location
United States
Sponsor
University of Michigan
View Trial →

Related Conditions

suicidal ideation (4) suicide (3) suicide and self harm (1) suicide threat (1) suicidal (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology